Skip to content

Ayurvedic Treatment for Stree Vandhyatva

Clinical Study To Evaluate The Efficacy of Kashmaryadi Ghrita With Yava kshara Uttarabasti And Oral Administration of Baladi Ghanvati In Stree Vandhyatva. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055561
Enrollment
30
Registered
2023-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N972- Female infertility of uterine origin

Interventions

Intervention1: Uttara Basti(Intra Uterine Uttara Basti) with Kashmaryadi Ghrita with Yava kshara And Oral Administration of Baladi Ghanavati.: Uttarabasti(IUUB)- Duration of IUUB-From 8th day Onwards

Sponsors

Parul Institute of ayurved
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Married Women with history of either primary or secondary infertility. Married Women aged between 20 to 40 years. Tubal factors, thin endometrium. Women with history of recurrent abortion. With either Regular or Irregular cycle. Subjects willing to give informed written consent

Exclusion criteria

Exclusion criteria: Women with Endometriosis, Adenomyosis, Uterine myoma. Infertility due to PCOD/other ovarian causes. Subjects using OCPills, with IUCD, known cervical factors of infertility. Patients having Carcinoma of reproductive tract. Patients having active inflammatory diseases e.g. Acute PID, STD like HIV, VDRL, HBsAg, HCV and TORCH positive. Patient having Congenital anomaly of reproductive tract. Patients having uncontrolled Hypertension, Type 2 DM, Hyperprolactinemia, Thyroid dysfunction, and any other severe systemic disease. Abnormalities in semen analysis.

Design outcomes

Primary

MeasureTime frame
To provide safe, cost effective & non- surgical treatment for the management of female infertility.Timepoint: 2 Month with 1 Month follow up.

Secondary

MeasureTime frame
To evaluate efficacy of Uttarabasti in menstrual abnormalities like Scanty menstruation, irregular menstruation, dysmenorrhea.Timepoint: 2 Month with 1 Month follow up.

Countries

India

Contacts

Public ContactDr Rita Makim

Parul Institute of Ayurved

ritamakim@gmail.com7990727524

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026